Skip to content

The sun rises following the revelation of our child's Angelman syndrome condition

Joelene Wand pens down her first article for "Here Comes the Sun," where she narrates her son Jude's battle with Angelman syndrome.

Sunshine emerges following the revelation of our child's Angelman syndrome diagnosis
Sunshine emerges following the revelation of our child's Angelman syndrome diagnosis

The sun rises following the revelation of our child's Angelman syndrome condition

In a heartfelt column, Joelene Wand, a 33-year-old lawyer from Sydney, shares her family's journey since receiving a diagnosis of Angelman syndrome for her 1.5-year-old son, Jude, on April 5.

Jude, an adventurous eater who loves being in the pool, is unique yet shares some characteristic features of those living with Angelman syndrome. These features often include frequent smiling and laughter, intellectual disability, difficulty with balance and movement, and little to no speech.

Despite these challenges, Jude works hard during therapy sessions, demonstrating determination and persistence. Physiotherapy, however, is not his favourite activity.

The column aims to spark discussion about issues pertaining to Angelman syndrome and connect with caregivers worldwide who are dealing with the condition. It provides support and encouragement, reminding us that every person living with Angelman syndrome is unique and deserves our understanding and support.

It is important to note that the column does not provide medical advice, diagnosis, or treatment for Angelman syndrome. Readers are advised to always seek the advice of their physician or other qualified health provider regarding medical conditions.

Currently, there is no cure for Angelman syndrome, but clinical trials are being conducted to restore the function of the UBE3A gene. The absence or malfunction of this gene on chromosome 15 is what causes Angelman syndrome, a rare neurogenetic disorder present in approximately 1 in 12,000 people.

Joelene Wand and her family have connected with families worldwide whose lives are touched by Angelman syndrome and other rare diseases. They stand as a testament to the resilience and strength of families affected by these conditions.

The opinions expressed in the column are not those of Angelman Syndrome News or its parent company, Bionews. The column serves as a platform for sharing personal experiences and fostering a supportive community for those affected by Angelman syndrome.

As we continue to learn more about this condition and the potential for treatment, it is crucial that we remain informed, supportive, and understanding. For more information about Angelman syndrome, please consult reliable resources and speak with your healthcare provider.

Read also: